Status:

RECRUITING

a Cohort Study of Ischemic Cerebrovascular Disease

Lead Sponsor:

Xiangya Hospital of Central South University

Conditions:

Ischaemic Stroke

Eligibility:

All Genders

18+ years

Brief Summary

This study aims to establish a multicenter, large-scale, prospective cohort of patients with ischemic stroke. Various biological samples such as blood, feces, and urine are collected to identify bioma...

Eligibility Criteria

Inclusion Criteria:

  1. Clinical diagnosis of ischemic stroke.
  2. Age ≥ 18 years.
  3. Signed informed consent form.

Exclusion Criteria:

  1. Patients with moderate to severe mental disorders or dementia who cannot cooperate to complete the informed consent and follow-up procedures.
  2. Patients with neurological functional impairment caused by conditions such as migraine aura, epilepsy, or other non-ischemic strokes.
  3. Agitated patients who cannot cooperate with imaging examinations.
  4. Pregnant or lactating patients, as well as those planning to become pregnant within 90 days.
  5. Patients with concurrent malignant tumors or severe systemic diseases with an expected survival period of less than 90 days.
  6. Patients who have participated in other clinical studies within 30 days prior to enrollment or are currently participating in other interventional clinical studies.

Key Trial Info

Start Date :

November 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2027

Estimated Enrollment :

5000 Patients enrolled

Trial Details

Trial ID

NCT05922540

Start Date

November 1 2022

End Date

November 1 2027

Last Update

June 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Xiangya Hospital, Central South University

Hunan, China, 410008

a Cohort Study of Ischemic Cerebrovascular Disease | DecenTrialz